LONDON, May 18, 2021 – Prescient, a biopharma product and portfolio strategy partner, has announced the recent appointment of two new senior members: Dr. John Crowley and Sugandh Sharma. They join the existing leadership team, which shapes the competitive strategies of Prescient’s clients through dynamic decision support.
John is a Director in Prescient’s Intelligence & Insight business. He earned his PhD in neuroscience from UMass Medical School and his BS in biochemistry from Worcester Polytechnic Institute. He has 10 years of experience in disease landscape analysis, market research and forecasting. Before joining Prescient, John led analyst teams at Decision Resources Group, covering rare diseases in the neurology, immunology and hematology spaces, as well as infectious diseases. At Prescient, John is responsible for driving the growth of the Intelligence & Insight team by ensuring engagements are of high quality, increasing Prescient’s expertise in the Boston area and supporting the team’s professional development.
Sugandh is a Senior Director in Prescient’s Intelligence & Insight business. She holds an MS in biotechnology and has over 14 years of experience in setting up new businesses and delivering strong commercial performance and growth in the healthcare consulting, research and intelligence sectors. In her previous roles, Sugandh has led multiple engagements with biopharmaceutical and healthcare companies in the commercial strategy, market access and research and intelligence domains across various disease segments. At Prescient, Sugandh is responsible for driving growth within the Intelligence & Insight business by developing successful engagements with clients and coaching teams to deliver high-quality insights and impact.
“Our clients partner with Prescient to maximize their products’ clinical and commercial differentiation and deliver maximum value to all key stakeholders. We support pharma’s cross-functional development and commercial teams throughout the product life cycle, and help them make confident decisions at critical inflection points that are underpinned by dynamic market insights and robust science,” says Dr Rakesh Verma, Prescient’s President. “John and Sugandh bring extensive pharma consulting experience and deep-rooted scientific expertise to support pharma’s development and commercial teams in delivering meaningfully differentiated medicinal products that meet stakeholders’ needs.”
Biographies and contact information for the Prescient Intelligence & Insight team can be found on www.PrescientHG.com.